DE69629838D1 - Inhibitoren der kainsäure-neurotoxizität sowie pyridothiazinderivate - Google Patents

Inhibitoren der kainsäure-neurotoxizität sowie pyridothiazinderivate

Info

Publication number
DE69629838D1
DE69629838D1 DE69629838T DE69629838T DE69629838D1 DE 69629838 D1 DE69629838 D1 DE 69629838D1 DE 69629838 T DE69629838 T DE 69629838T DE 69629838 T DE69629838 T DE 69629838T DE 69629838 D1 DE69629838 D1 DE 69629838D1
Authority
DE
Germany
Prior art keywords
formula
kainic acid
inhibitors
neuronotoxicity
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69629838T
Other languages
English (en)
Other versions
DE69629838T2 (de
Inventor
Jun-Ichi Shishikura
Hiroshi Inami
Tomoyuki Yasunaga
Masaaki Hirano
Shuichi Sakamoto
Kazushige Ohno
Masamichi Okada
Shin-Ichi Tsukamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69629838D1 publication Critical patent/DE69629838D1/de
Publication of DE69629838T2 publication Critical patent/DE69629838T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
DE69629838T 1995-11-15 1996-11-14 Inhibitoren der kainsäure-neurotoxizität sowie pyridothiazinderivate Expired - Fee Related DE69629838T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29685795 1995-11-15
JP29685795 1995-11-15
PCT/JP1996/003339 WO1997017970A1 (fr) 1995-11-15 1996-11-14 Inhibiteurs de la neurotoxicite de l'acide kainique et derives de la pyridothiazine

Publications (2)

Publication Number Publication Date
DE69629838D1 true DE69629838D1 (de) 2003-10-09
DE69629838T2 DE69629838T2 (de) 2004-07-08

Family

ID=17839067

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69629838T Expired - Fee Related DE69629838T2 (de) 1995-11-15 1996-11-14 Inhibitoren der kainsäure-neurotoxizität sowie pyridothiazinderivate

Country Status (12)

Country Link
US (1) US6133258A (de)
EP (1) EP0878196B1 (de)
JP (1) JP3117725B2 (de)
KR (1) KR100444697B1 (de)
CN (1) CN1202109A (de)
AT (1) ATE248598T1 (de)
AU (1) AU713847B2 (de)
CA (1) CA2237911A1 (de)
DE (1) DE69629838T2 (de)
ES (1) ES2206604T3 (de)
TW (1) TW446708B (de)
WO (1) WO1997017970A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles
JP2002519373A (ja) 1998-07-02 2002-07-02 エーザイ株式会社 製薬組成物及びそれらの使用
WO2000051992A1 (en) * 1999-03-04 2000-09-08 E.I. Du Pont De Nemours And Company Fused bicyclic oxazinone and thiazinone fungicides
DE60041365D1 (de) * 1999-06-04 2009-02-26 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Verwendung von Riluzol zur Behandlung Multipler Sklerose
ES2235896T3 (es) * 1999-06-04 2005-07-16 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Uso de riluzol para el tratamaiento de la esclerosis multiple.
KR20040097236A (ko) * 2002-03-29 2004-11-17 야마노우치세이야쿠 가부시키가이샤 신경 교아종 치료제
AU2003295605A1 (en) 2002-11-19 2004-06-15 Achillion Pharmaceuticals, Inc. Substituted aryl thioureas and releated compounds; inhibitors of viral replication
TW200600492A (en) 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
CN104672256B (zh) * 2013-11-29 2017-10-31 沈阳药科大学 4H‑吡啶并[3,2‑e][1,3]噻嗪‑4‑酮类衍生物及其应用
WO2016039936A2 (en) * 2014-09-09 2016-03-17 Ptc Therapeutics, Inc. Monocyclic substituted 2-pyridinone antibacterial compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157647A (en) * 1960-10-31 1964-11-17 Olin Mathieson Process for producing nu-alkyl and nu-aralkyl thiadiazine compounds
US3288678A (en) * 1963-09-12 1966-11-29 Ciba Geigy Corp Diuretic compositions
GB1368948A (en) * 1970-11-11 1974-10-02 Manuf Prod Pharma Pyridine derivatives
FR2703051B1 (fr) * 1993-03-26 1995-04-28 Adir Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
FR2722502B1 (fr) * 1994-07-12 1996-08-23 Adir Nouveau derive de benzothiadiazine, son procede depreparation et les compositions pharmaceutiques qui le contiennent

Also Published As

Publication number Publication date
AU7587096A (en) 1997-06-05
EP0878196A1 (de) 1998-11-18
KR100444697B1 (ko) 2005-01-13
CN1202109A (zh) 1998-12-16
EP0878196A4 (de) 2001-04-11
DE69629838T2 (de) 2004-07-08
WO1997017970A1 (fr) 1997-05-22
EP0878196B1 (de) 2003-09-03
CA2237911A1 (en) 1997-05-22
US6133258A (en) 2000-10-17
AU713847B2 (en) 1999-12-09
KR19990067528A (ko) 1999-08-25
TW446708B (en) 2001-07-21
ATE248598T1 (de) 2003-09-15
ES2206604T3 (es) 2004-05-16
JP3117725B2 (ja) 2000-12-18

Similar Documents

Publication Publication Date Title
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
CA2311742A1 (en) 6-amino-9-benzyl-8-hydroxypurine derivatives
ATE211734T1 (de) Stickstoff enthaltende hydrocyclische verbindungen
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
DE69320869T2 (de) Hydroxamsäure Derivate als Collagenase Inhibitore
DE69528005T2 (de) Prolineamid-Derivate
DE69309435D1 (de) Restenosehemmer nach perkutaner koronarer arterioplastie
ATE248598T1 (de) Inhibitoren der kainsäure-neurotoxizität sowie pyridothiazinderivate
DK0916651T3 (da) Phenylalkylcarboxylsyrederivater
ATE182331T1 (de) Oxazolidone derivative als monoamine- oxidaseinhibitoren
ATE194982T1 (de) Benzoxazepin-derivate als cholinesterase- inhibitoren
ATE165083T1 (de) N-arylalkylphenylacetamidderivate

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ASTELLAS PHARMA INC., TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee